Diminished prevalence but preserved synaptic distribution of N-methyl-d-aspartate receptor subunits in the methyl CpG binding protein 2(MeCP2)-null mouse brain

Neuroscience

Volumn 168, Issue 3, 2010, Pages 624-632

  Maliszewska Cyna, E ^a,b   Bawa, D ^a   Eubanks, J H ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Autism spectrum disorder; Brain; Lipid raft; Methyl DNA binding factor; Post synaptic density

Indexed keywords

DETERGENT; METHYL CPG BINDING PROTEIN 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; RECEPTOR SUBUNIT; PROTEIN SUBUNIT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN REGION; CONTROLLED STUDY; GENE MUTATION; MOUSE; NONHUMAN; ONTOGENY; PATHOPHYSIOLOGY; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETT SYNDROME; SYNAPTIC MEMBRANE; ANIMAL; BRAIN; CELL MEMBRANE; GENETICS; IN VITRO STUDY; KNOCKOUT MOUSE; MALE; METABOLISM; PROTEIN SUBUNIT; SOLUBILITY; SYNAPSE;

ANIMALS; BRAIN; DETERGENTS; MALE; MEMBRANE MICRODOMAINS; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, KNOCKOUT; PROTEIN SUBUNITS; RECEPTORS, N-METHYL-D-ASPARTATE; SOLUBILITY; SYNAPSES; SYNAPTIC MEMBRANES; IN VITRO TECHNIQUES;

EID: 77953122395     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.03.065     Document Type: Article

References (57)

1. Abuhatzira L., Makedonski K., Kaufman Y., Razin A., Shemer R. MeCP2 deficiency in the brain decreases BDNF levels by REST/CoREST-mediated repression and increases TRKB production. Epigenetics 2007, 2:214-222.
2. Adachi M., Autry A.E., Covington H.E., Monteggia L.M. MeCP2-mediated transcription repression in the basolateral amygdala may underlie heightened anxiety in a mouse model of Rett syndrome. J Neurosci 2009, 29:4218-4227.
3. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23:185-188.
4. Armstrong D.D. Neuropathology of Rett syndrome. Ment Retard Dev Disabil Res Rev 2002, 8:72-76.
5. Armstrong D.D., Dunn K., Antalffy B. Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J Neuropathol Exp Neurol 1998, 57:1013-1017.
6. Asaka Y., Jugloff D.G., Zhang L., Eubanks J.H., Fitzsimonds R.M. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol Dis 2006, 21:217-227.
7. Belichenko N.P., Belichenko P.V., Mobley W.C. Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation. Neurobiol Dis 2009, 34:71-77.
8. Bellone C., Nicoll R.A. Rapid bidirectional switching of synaptic NMDA receptors. Neuron 2007, 55:779-785.
9. Besshoh S., Bawa D., Teves L., Wallace M.C., Gurd J.W. Increased phosphorylation and redistribution of NMDA receptors between synaptic lipid rafts and post-synaptic densities following transient global ischemia in the rat brain. J Neurochem 2005, 93:186-194.
10. Besshoh S., Chen S., Brown I.R., Gurd J.W. Developmental changes in the association of NMDA receptors with lipid rafts. J Neurosci Res 2007, 85:1876-1883.
11. Bickel P.E., Scherer P.E., Schnitzer J.E., Oh P., Lisanti M.P., Lodish H.F. Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J Biol Chem 1997, 272:13793-13802.
12. Blue M.E., Naidu S., Johnston M.V. Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Exp Neurol 1999, 156:345-352.
13. Blue M.E., Naidu S., Johnston M.V. Development of amino acid receptors in frontal cortex from girls with Rett syndrome. Ann Neurol 1999, 45:541-545.
14. Caldeira M.V., Melo C.V., Pereira D.B., Carvalho R.F., Carvalho A.L., Duarte C.B. BDNF regulates the expression and traffic of NMDA receptors in cultured hippocampal neurons. Mol Cell Neurosci 2007, 35:208-219.
15. Chahrour M., Jung S.Y., Shaw C., Zhou X., Wong S.T., Qin J., Zoghbi H.Y. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008, 320:1224-1229.
16. Chang Q., Khare G., Dani V., Nelson S., Jaenisch R. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 2006, 49:341-348.
17. Chazot P.L., Stephenson F.A. Biochemical evidence for the existence of a pool of unassembled C2 exon-containing NR1 subunits of the mammalian forebrain NMDA receptor. J Neurochem 1997, 68:507-516.
18. Chen Q., He S., Hu X.L., Yu J., Zhou Y., Zheng J., Zhang S., Zhang C., Duan W.H., Xiong Z.Q. Differential roles of NR2A- and NR2B-containing NMDA receptors in activity-dependent brain-derived neurotrophic factor gene regulation and limbic epileptogenesis. J Neurosci 2007, 27:542-552.
19. Chen R.Z., Akbarian S., Tudor M., Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 2001, 27:327-331.
20. Chen W.G., Chang Q., Lin Y., Meissner A., West A.E., Griffith E.C., Jaenisch R., Greenberg M.E. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 2003, 302:885-889.
21. Colantuoni C., Jeon O.H., Hyder K., Chenchik A., Khimani A.H., Narayanan V., Hoffman E.P., Kaufmann W.E., Naidu S., Pevsner J. Gene expression profiling in postmortem Rett syndrome brain: differential gene expression and patient classification. Neurobiol Dis 2001, 8:847-865.
22. Collingridge G.L., Olsen R.W., Peters J., Spedding M. A nomenclature for ligand-gated ion channels. Neuropharmacology 2009, 56:2-5.
23. Cull-Candy S., Brickley S., Farrant M. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 2001, 11:327-335.
24. Fu Z., Logan S.M., Vicini S. Deletion of the NR2A subunit prevents developmental changes of NMDA-mEPSCs in cultured mouse cerebellar granule neurones. J Physiol 2005, 563:867-881.
25. Fukuda T., Itoh M., Ichikawa T., Washiyama K., Goto Y. Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J Neuropathol Exp Neurol 2005, 64:537-544.
26. Fyffe S.L., Neul J.L., Samaco R.C., Chao H.T., Ben-Shachar S., Moretti P., McGill B.E., Goulding E.H., Sullivan E., Tecott L.H., Zoghbi H.Y. Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron 2008, 59:947-958.
27. Gardoni F. MAGUK proteins: new targets for pharmacological intervention in the glutamatergic synapse. Eur J Pharmacol 2008, 585:147-152.
28. Gemelli T., Berton O., Nelson E.D., Perrotti L.I., Jaenisch R., Monteggia L.M. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Biol Psychiatry 2006, 59:468-476.
29. Glaze D.G. Rett syndrome: of girls and mice-lessons for regression in autism. Ment Retard Dev Disabil Res Rev 2004, 10:154-158.
30. Guy J., Hendrich B., Holmes M., Martin J.E., Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 2001, 27:322-326.
31. Huh K.H., Wenthold R.J. Turnover analysis of glutamate receptors identifies a rapidly degraded pool of the N-methyl-D-aspartate receptor subunit, NR1, in cultured cerebellar granule cells. J Biol Chem 1999, 274:151-157.
32. Jellinger K., Seitelberger F. Neuropathology of Rett syndrome. Am J Med Genet Suppl 1986, 1:259-288.
33. Johnston M.V., Jeon O.H., Pevsner J., Blue M.E., Naidu S. Neurobiology of Rett syndrome: a genetic disorder of synapse development. Brain Dev 2001, 1:S206-S213.
34. Jung B.P., Jugloff D.G., Zhang G., Logan R., Brown S., Eubanks J.H. The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. J Neurobiol 2003, 55:86-96.
35. Kishi N., Macklis J.D. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 2004, 27:306-321.
36. Lee S., Kim W., Ham B.J., Chen W., Bear M.F., Yoon B.J. Activity-dependent NR2B expression is mediated by MeCP2-dependent epigenetic regulation. Biochem Biophys Res Commun 2008, 377:930-934.
37. Leontovich T.A., Mukhina J.K., Fedorov A.A., Belichenko P.V. Morphological study of the entorhinal cortex, hippocampal formation, and basal ganglia in Rett syndrome patients. Neurobiol Dis 1999, 6:77-91.
38. Margottil E., Domenici L. NR2A but not NR2B N-methyl-D-aspartate receptor subunit is altered in the visual cortex of BDNF-knock-out mice. Cell Mol Neurobiol 2003, 23:165-174.
39. Martinowich K., Hattori D., Wu H., Fouse S., He F., Hu Y., Fan G., Sun Y.E. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 2003, 302:890-893.
40. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994, 12:529-540.
41. Mullaney B.C., Johnston M.V., Blue M.E. Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain. Neuroscience 2004, 123:939-949.
42. Nakanishi S., Masu M., Bessho Y., Nakajima Y., Hayashi Y., Shigemoto R. Molecular diversity of glutamate receptors and their physiological functions. EXS 1994, 71:71-80.
43. Paladino T., Beesley P.W., Gurd J.W. Molecular characterization of GP50: a neuron-specific, synaptic-enriched glycoprotein. J Neurochem 1989, 53:1902-1909.
44. Percy A.K. Rett syndrome. Current status and new vistas. Neurol Clin 2002, 20:1125-1141.
45. Petralia R.S., Sans N., Wang Y.X., Wenthold R.J. Ontogeny of postsynaptic density proteins at glutamatergic synapses. Mol Cell Neurosci 2005, 29:436-452.
46. Rett A. Über eine eiggenartiges hirnatrophisches syndrome bei hyperammonamie im Kindesalter. Wien Med Wochenschr 1966, 116:723-726.
47. Samaco R.C., Mandel-Brehm C., Chao H.T., Ward C.S., Fyffe-Maricich S.L., Ren J., Hyland K., Thaller C., Maricich S.M., Humphreys P., Greer J.J., Percy A., Glaze D.G., Zoghbi H.Y., Neul J.L. Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc Natl Acad Sci U S A 2009, 106:21966-21971.
48. Sans N., Petralia R.S., Wang Y.X., Blahos J., Hell J.W., Wenthold R.J. A developmental change in NMDA receptor-associated proteins at hippocampal synapses. J Neurosci 2000, 20:1260-1271.
49. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., Armstrong D., Paylor R., Zoghbi H. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002, 35:243-254.
50. Stearns N.A., Schaevitz L.R., Bowling H., Nag N., Berger U.V., Berger-Sweeney J. Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome. Neuroscience 2007, 146:907-921.
51. Townsend M., Yoshii A., Mishina M., Constantine-Paton M. Developmental loss of miniature N-methyl-D-aspartate receptor currents in NR2A knockout mice. Proc Natl Acad Sci U S A 2003, 100:1340-1345.
52. Tropea D., Giacometti E., Wilson N.R., Beard C., McCurry C., Fu D.D., Flannery R., Jaenisch R., Sur M. Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci U S A 2009, 106:2029-2034.
53. van Zundert B., Yoshii A., Constantine-Paton M. Receptor compartmentalization and trafficking at glutamate synapses: a developmental proposal. Trends Neurosci 2004, 27:428-437.
54. Wang H., Chan S.A., Ogier M., Hellard D., Wang Q., Smith C., Katz D.M. Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice. J Neurosci 2006, 26:10911-10915.
55. Watanabe M., Inoue Y., Sakimura K., Mishina M. Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport 1992, 3:1138-1140.
56. Wenzel A., Fritschy J.M., Mohler H., Benke D. NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins. J Neurochem 1997, 68:469-478.
57. Wood L., Gray N.W., Zhou Z., Greenberg M.E., Shepherd G.M. Synaptic circuit abnormalities of motor-frontal layer 2/3 pyramidal neurons in an RNA interference model of methyl-CpG-binding protein 2 deficiency. J Neurosci 2009, 29:12440-12448.